Home/Filings/4/0001532023-24-000008
4//SEC Filing

Gangolli Julian S 4

Accession 0001532023-24-000008

CIK 0001711279other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 6:17 PM ET

Size

12.1 KB

Accession

0001532023-24-000008

Insider Transaction Report

Form 4
Period: 2024-05-20
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-20$22.75/sh+20,000$455,00020,000 total
  • Sale

    Common Stock

    2024-05-20$164.34/sh7,090$1,165,1801,980 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-2020,0000 total
    Exercise: $22.75Exp: 2029-03-01Common Stock (20,000 underlying)
  • Sale

    Common Stock

    2024-05-20$165.76/sh1,980$328,2000 total
  • Sale

    Common Stock

    2024-05-20$163.71/sh10,930$1,789,3109,070 total
Footnotes (4)
  • [F1]The transaction was executed in multiple trades ranging from $163.080 to $164.065. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F2]The transaction was executed in multiple trades ranging from $164.085 to $164.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The transaction was executed in multiple trades ranging from $165.160 to $166.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]The options were awarded on March 1, 2019 and vested monthly over a three-year period.

Issuer

Krystal Biotech, Inc.

CIK 0001711279

Entity typeother

Related Parties

1
  • filerCIK 0001532023

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:17 PM ET
Size
12.1 KB